Julie Vose MD, MBA, FASCO is a board-certified hematology and medical oncology physician on faculty at the University of Nebraska Medical Center in Omaha, Nebraska.
She is the Neumann M. and Mildred E. Harris Professor and Chief of the Division of Hematology/Oncology at the University of Nebraska Medical Center. A leader in Hogdkin and non-Hodgkin lymphoma, Dr Vose serves in multiple leadership roles including as the Associate Director of Clinical Research and Co-Leader of Lymphoma Research Program at the Fred & Pamela Buffet Cancer Center, Co-Director of the Nebraska Lymphoma Study Group, a member of the Lymphoma Standards Committee at National Comprehensive Cancer Network, and a member of the editorial board for Clinical Lymphoma, Myeloma & Leukemia.
She is an ad hoc reviewer for at least 10 peer-reviewed journals. From 2015-2016, Dr Vose served as President of the American Society of Clinical Oncology (ASCO). She is the recipient of the 2009 Carol Bell Cancer Research Award given by the Fred & Pamela Buffet Cancer Center and the 2009 Department of Internal Medicine Career Investigator Award given by the University of Nebraska Medical Center. Dr Vose has authored or coauthored at least 490 peer-reviewed journal articles, at least 46 book chapters, and at least 2 books.
She is a member of ASCO, the American Society of Hematology, the American Society for Blood and Marrow Transplantation, and the International Society of Experimental Hematology. Dr Vose’s clinical research focus includes novel therapies for Hodgkin lymphoma, non-Hodgkin lymphoma, multiple myeloma, and chronic lymphocytic leukemia.